Gilead Sciences, Inc.
Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections

Last updated:

Abstract:

Provided herein are formulations, methods and substituted tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds of Formula (I) for treating Pneumovirinae virus infections, including respiratory syncytial virus infections, as well as methods and intermediates for synthesis of tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

25 Jul 2018

Issue date:

13 Aug 2019